Integer (ITGR) Stock Forecast, Price & News

5 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Integer in the last twelve months. There are currently 3 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" ITGR shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in ITGR, but not buy additional shares or sell existing shares.
View ITGR analyst ratings or view top-rated stocks.

5 brokers have issued twelve-month price objectives for Integer's shares. Their ITGR share price forecasts range from $85.00 to $96.00. On average, they predict the company's share price to reach $88.67 in the next year. This suggests a possible upside of 5.2% from the stock's current price.
View analysts price targets for ITGR or view top-rated stocks among Wall Street analysts.

Integer's stock was trading at $68.46 at the start of the year. Since then, ITGR stock has increased by 23.2% and is now trading at $84.31.
View the best growth stocks for 2023 here.

The company is scheduled to release its next quarterly earnings announcement on Thursday, July 27th 2023.
View our ITGR earnings forecast.

Integer Holdings Co. (NYSE:ITGR) posted its quarterly earnings data on Thursday, April, 27th. The medical equipment provider reported $0.87 earnings per share for the quarter, beating analysts' consensus estimates of $0.82 by $0.05. The medical equipment provider earned $378.79 million during the quarter, compared to analyst estimates of $352.43 million. Integer had a trailing twelve-month return on equity of 9.54% and a net margin of 4.71%. The firm's quarterly revenue was up 21.8% compared to the same quarter last year. During the same quarter in the previous year, the company earned $0.78 earnings per share.

ETFs with the largest weight of Integer (NYSE:ITGR) stock in their portfolio include Invesco S&P SmallCap Health Care ETF (PSCH), SPDR S&P Health Care Equipment ETF (XHE), iShares S&P Small-Cap 600 Value ETF (IJS), SPDR S&P 600 Small CapValue ETF (SLYV), Vanguard S&P Small-Cap 600 Value ETF (VIOV), Dimensional US Small Cap Value ETF (DFSV), Timothy Plan US Small Cap Core ETF (TPSC) and iShares ESG Screened S&P Small-Cap ETF (XJR).

Integer updated its FY 2023 earnings guidance on Thursday, April, 27th. The company provided earnings per share (EPS) guidance of $4.00-$4.30 for the period, compared to the consensus earnings per share estimate of $4.13. The company issued revenue guidance of $1.47 billion-$1.50 billion, compared to the consensus revenue estimate of $1.49 billion.

40 employees have rated Integer Chief Executive Officer Joseph Dziedzic on Glassdoor.com. Joseph Dziedzic has an approval rating of 86% among the company's employees.

Based on aggregate information from My MarketBeat watchlists, some companies that other Integer investors own include Abbott Laboratories (ABT), Pfizer (PFE), Procter & Gamble (PG), Gilead Sciences (GILD), Coca-Cola (KO), AT&T (T), AbbVie (ABBV), Advanced Micro Devices (AMD), Cisco Systems (CSCO) and General Mills (GIS).

Integer trades on the New York Stock Exchange (NYSE) under the ticker symbol "ITGR."

Integer's stock is owned by a variety of institutional and retail investors. Top institutional investors include BlackRock Inc. (16.49%), Franklin Resources Inc. (7.39%), Dimensional Fund Advisors LP (6.45%), Victory Capital Management Inc. (4.28%), State Street Corp (4.01%) and Silvercrest Asset Management Group LLC (3.00%). Insiders that own company stock include Anthony W Borowicz, Bill R Sanford, Bill R Sanford, Carter Houghton, Jean M Hobby, Joseph F Flanagan, Joseph W Dziedzic and Pamela G Bailey.
View institutional ownership trends.

Shares of ITGR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of ITGR stock can currently be purchased for approximately $84.31.

Integer (NYSE:ITGR) has a market capitalization of $2.81 billion and generates $1.44 billion in revenue each year. The medical equipment provider earns $66.38 million in net income (profit) each year or $2.03 on an earnings per share basis.

The company employs 10,000 workers across the globe.

Integer's mailing address is 5830 Granite Parkway Suite 1150, Plano TX, 75024. The official website for the company is www.integer.net. The medical equipment provider can be reached via phone at (214) 618-5243, via email at ir@integer.net, or via fax at 716-759-5654.